Form 4: Myomo Inc. Chief Medical Officer Harry Kovelman Reports Stock Sale to Cover Taxes
SEC Form 4
Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 121 shares of common stock on November 4, 2024, to cover income taxes due on vesting of restricted stock units.
Summary
- On November 4, 2024, Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 121 shares of common stock.
- The sale was executed at a price of $3.7 per share.
- This transaction was conducted to cover income taxes resulting from the vesting of restricted stock units on November 2, 2024.
- The sale was pursuant to an irrevocable election made by Kovelman in conjunction with the original grant in November 2020.
- Following the transaction, Kovelman beneficially owns 123,314 shares of Myomo, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This is a routine Form 4 filing, reflecting an insider's stock sale to cover tax obligations related to vested equity compensation, a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| November 2020 | Original grant of restricted stock units with irrevocable election. |
| November 2, 2024 | Vesting of restricted stock units. |
| November 4, 2024 | Sale of 121 shares of common stock. |
| 11/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.